| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 21 May 2024 | 10 May 2024 |
| LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve The Company has informed that the meeting of Board of Directors of the Company is scheduled on 21st May 2024 to consider and approve standalone and consolidated financial results for the year ended 31st March 2024. The Board Meeting to be held on 21/05/2024 has been revised to 21/05/2024 Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to our prior intimations dated 10th May 2024, relating to the Board Meeting scheduled on Tuesday, 21st May 2024, this is to inform you that the said meeting is rescheduled at 03:30 p.m. instead of 12:00 noon, inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and financial year ended on 31st March 2024. (As Per BSE Announcement Dated on 14.05.2024) Outcome of Board Meeting (As Per BSE Announcement Dated on 21/05/2024) | ||
| Board Meeting | 16 Apr 2024 | 8 Apr 2024 |
| LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2024 inter alia to consider and approve to allot and issue 2600000 equity shares upon conversion of 2600000 warrants to Ipca Laboratories Limited. Outcome of Board Meeting (As Per BSE Announcement Dated on 16.04.2024) | ||
| Board Meeting | 8 Feb 2024 | 31 Jan 2024 |
| LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended on 31st December 2023 to be held on Thursday 8th February 2024 at 12:00 noon at 125 - Charkop Road Charkop Industrial Estate Kandivali West Mumbai - 400 067. Outcome of Board Meeting held on 8th February 2024 Financial Results for the quarter and nine months ended 31.12.2023 (As per BSE Announcement Dated on 08/02/2024) | ||
| Board Meeting | 16 Jan 2024 | 16 Jan 2024 |
| Pursuant to NCLT Order dated 8.01.2024, the Board of Directors in its meeting held on 16th January 2024 has consented to convey meetings of its shareholders and creditors Board of Directors of the Company, in its meeting held on 16trh January 2024, has decided to to seek consent of members through postal ballot. (As per BSE Announcement Dated on 16/01/2024) | ||
| Board Meeting | 2 Nov 2023 | 20 Oct 2023 |
| LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve The meeting of the Board of Directors of the Company to be held on Thursday 2nd November 2023 at 12:00 noon at 125 - Charkop Road Charkop Industrial Estate Kandivali West Mumbai - 400 067 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on 30th September 2023. Outcome of the Board Meeting held on 02.11.2023 (As Per BSE Announcement dated on 02.11.2023) | ||
| Board Meeting | 2 Aug 2023 | 26 Jul 2023 |
| LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 inter alia to consider and approve Meeting of the Board of Directors of the Company to be held on Wednesday 2nd August 2023 at 1.00 p.m. at Ground Floor Spencer Building 30 Forjett Street Grant Road (West) Mumbai - 400 036 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June 2023. In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; the Board of Directors at its Meeting held today i.e. 2nd August 2023 inter alia considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2023 together with the Limited Review Reports thereon. The said Financial Results along with Limited Review Report are attached herewith. The meeting of the Board of Directors commenced at 01:00 p.m. and concluded at 01:50 p.m. The Board of Directors at its meeting held today i.e. 2nd August 2023 inter-alia considered and approved unaudited standalone and consolidated financial results for the quarter ended 30th June 2023. (As Per BSE Announcement Dated on 02.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
